Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugh Bostock

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 3, 2004
Has potassium been prematurely discarded as a contributing factor to the development of uraemic neuropathy?Hugh Bostock, Richard J L Walters, Kjeld V Andersen, et al.
Brain : a Journal of Neurology|April 26, 2006
Ischaemia induces paradoxical changes in axonal excitability in end-stage kidney diseaseArun V Krishnan, Richard K S Phoon, Bruce A Pussell, et al.
Brain : a Journal of Neurology|June 11, 2005
Altered motor nerve excitability in end-stage kidney diseaseArun V Krishnan, Richard K S Phoon, Bruce A Pussell, et al.
Brain : a Journal of Neurology|February 10, 2006
Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stageKazuaki Kanai, Satoshi Kuwabara, Sonoko Misawa, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|December 14, 2017
Axonal excitability changes and acute symptoms of oxaliplatin treatment: In vivo evidence for slowed sodium channel inactivationRikke Heide, Hugh Bostock, Lise Ventzel, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 7, 2006
Neuropathy, axonal Na+/K+ pump function and activity-dependent excitability changes in end-stage kidney diseaseArun V Krishnan, Richard K S Phoon, Bruce A Pussell, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 24, 2017
Nerve excitability changes related to muscle weakness in chronic progressive external ophthalmoplegiaAntoine Gueguen, Claude Jardel, Marc Polivka, et al.
Muscle & Nerve|December 25, 2003
Threshold electrotonus in chronic inflammatory demyelinating polyneuropathy: correlation with clinical profilesJia-Ying Sung, Satoshi Kuwabara, Ryuji Kaji, et al.
Clinical Neurophysiology Practice|April 9, 2025
Muscle excitability testing: Age and sex dependency of normative dataMatthias Thomas Exl, Belén Rodriguez, Karl Ng, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 28, 2022
Three different short-interval intracortical inhibition methods in early diagnosis of amyotrophic lateral sclerosisHatice Tankisi, Hossein Pia, Kristine Strunge, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 3, 2004
Has potassium been prematurely discarded as a contributing factor to the development of uraemic neuropathy?Hugh Bostock, Richard J L Walters, Kjeld V Andersen, et al.
Brain : a Journal of Neurology|April 26, 2006
Ischaemia induces paradoxical changes in axonal excitability in end-stage kidney diseaseArun V Krishnan, Richard K S Phoon, Bruce A Pussell, et al.
Brain : a Journal of Neurology|June 11, 2005
Altered motor nerve excitability in end-stage kidney diseaseArun V Krishnan, Richard K S Phoon, Bruce A Pussell, et al.
Brain : a Journal of Neurology|February 10, 2006
Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stageKazuaki Kanai, Satoshi Kuwabara, Sonoko Misawa, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|December 14, 2017
Axonal excitability changes and acute symptoms of oxaliplatin treatment: In vivo evidence for slowed sodium channel inactivationRikke Heide, Hugh Bostock, Lise Ventzel, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 7, 2006
Neuropathy, axonal Na+/K+ pump function and activity-dependent excitability changes in end-stage kidney diseaseArun V Krishnan, Richard K S Phoon, Bruce A Pussell, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 24, 2017
Nerve excitability changes related to muscle weakness in chronic progressive external ophthalmoplegiaAntoine Gueguen, Claude Jardel, Marc Polivka, et al.
Muscle & Nerve|December 25, 2003
Threshold electrotonus in chronic inflammatory demyelinating polyneuropathy: correlation with clinical profilesJia-Ying Sung, Satoshi Kuwabara, Ryuji Kaji, et al.
Clinical Neurophysiology Practice|April 9, 2025
Muscle excitability testing: Age and sex dependency of normative dataMatthias Thomas Exl, Belén Rodriguez, Karl Ng, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 28, 2022
Three different short-interval intracortical inhibition methods in early diagnosis of amyotrophic lateral sclerosisHatice Tankisi, Hossein Pia, Kristine Strunge, et al.
Pageof 11